Back to search

Article

Dual Bronchodilation with Tiotropium/Olodaterol: A Revised Cost-Utility Analysis for COPD in Colombia

2026-08-07

Abstract excerpt

<title>Abstract</title> <p> <bold>Introduction</bold> : Chronic obstructive pulmonary disease (COPD) imposes a substantial clinical and economic burden in Colombia. Contemporary GOLD recommendations emphasize long-acting muscarinic antagonist/long-acting beta2-agonist dual bronchodilation for symptomatic patients, but locally relevant economic evidence remains limited. <bold>Areas covered:</bold> We rebuilt a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c585c946-c4d7-524d-8ef4-085351da6b94
DOI
10.21203/rs.3.rs-10157749/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Dual Bronchodilation with Tiotropium/Olodaterol: A Revised Cost-Utility Analysis for COPD in ColombiaDOI 10.21203/rs.3.rs-10157749/v1
Forecasting the Long-Term Clinical and Economic Outcomes of Lumacaftor/Ivacaftor in Cystic Fibrosis Patients with Homozygous phe508del Mutation.Semantic proximity
High-flow nasal cannula for acute exacerbation of chronic obstructive pulmonary disease: a Cost-utility analysisSemantic proximity
Development and validation of the Evaluation Platform In COPD (EPIC): a population-based outcomes model of COPD for CanadaSemantic proximity
Exacerbations and Lung Function in Polish Patients with Chronic Obstructive Pulmonary Disease Treated with ICS/LABA: 2-Year Prospective, Observational StudySemantic proximity
Incremental cost-effectiveness analysis of tyrosine kinase inhibitors in advanced non-small cell lung cancer with mutations of the epidermal growth factor receptor in Colombia.Semantic proximity
Genotype-driven asthma prescribing of inhaled corticosteroids and long-acting β2-agonist: A cost-effectiveness analysis.Semantic proximity
Economic burden of Respiratory Syncytial Virus Infection in Colombia in 2019: A Cost-of-Illness StudySemantic proximity
Determining the return on investment of a global adaptive platform trial for critically ill patients during COVID-19: A value of implementation analysis in low- and middle-income countries and globallySemantic proximity
Cost-effectiveness analysis of triple therapy with protease inhibitors in treatment-naive hepatitis C patients.Semantic proximity
Generating Evidence for Chronic Obstructive Pulmonary Disease (COPD) Clinical Guidelines Using EHR DataSemantic proximity
Medical Costs of Alpha-1 Antitrypsin Deficiency-Associated COPD in the United StatesSemantic proximity
Costs of attributable burden disease to PM2.5 ambient air pollution exposure in Medellín, Colombia, 2010–2016Semantic proximity
Select a neighboring publication to make it the new centre.